The senior living services company's venture unit will invest up to $1m a time from the fund, raised in partnership with investment bank Ziegler.

The Germany-based company has now raised more than $190m since it was founded, with the Swisscom-backed Mona Lisa Fund among existing backers.

Qiagen-backed diagnostic technology developer Xagenic has raised $25.5m in a second closing of its series B round.

The pharmaceutical company, which has Novo as its third largest shareholder, will seek to raise up to $86.3m.

Houston Health Ventures launches its accelerator for health IT startups.

The Yaskawa-backed motorised prosthesis maker intends to invest the proceeds on expanding marketing and beginning work on the next generation of its technology.

The security software producer has now made five investments from its Silicon Valley-based fund and will target startups that are a strategic fit.

Accelera Diagnostics, a new startup, will commercialise up to 21 pharmaceuticals licensed to Sunbelt.